Daiwa Securities Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,369
| Closed | -$2K | – | 1398 |
|
|
2025
Q3 | $2K | Hold |
1,369
| – | – | ﹤0.01% | 1275 |
|
|
2025
Q2 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1267 |
|
|
2025
Q1 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1232 |
|
|
2024
Q4 | $1K | Hold |
1,369
| – | – | ﹤0.01% | 1256 |
|
|
2024
Q3 | $2K | Hold |
1,369
| – | – | ﹤0.01% | 1221 |
|
|
2024
Q2 | $2K | Buy |
1,369
+935
| +215% | +$1.68K | ﹤0.01% | 1253 |
|
|
2024
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1297 |
|
|
2023
Q4 | $1K | Hold |
434
| – | – | ﹤0.01% | 1300 |
|
|
2023
Q3 | $0 | Hold |
434
| – | – | ﹤0.01% | 1319 |
|
|
2023
Q2 | $1K | Hold |
434
| – | – | ﹤0.01% | 1282 |
|
|
2023
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1262 |
|
|
2022
Q4 | $1K | Hold |
434
| – | – | ﹤0.01% | 1277 |
|
|
2022
Q3 | $1K | Hold |
434
| – | – | ﹤0.01% | 1299 |
|
|
2022
Q2 | $1K | Hold |
434
| – | – | ﹤0.01% | 1299 |
|
|
2022
Q1 | $1K | Hold |
434
| – | – | ﹤0.01% | 1317 |
|
|
2021
Q4 | $2K | Buy |
+434
| New | +$2.11K | ﹤0.01% | 1287 |
|
|
2020
Q4 | – | Sell |
-583
| Closed | -$1K | – | 1284 |
|
|
2020
Q3 | $1K | Hold |
583
| – | – | ﹤0.01% | 1165 |
|
|
2020
Q2 | $1K | Hold |
583
| – | – | ﹤0.01% | 1188 |
|
|
2020
Q1 | $1K | Hold |
583
| – | – | ﹤0.01% | 1191 |
|
|
2019
Q4 | $2K | Hold |
583
| – | – | ﹤0.01% | 1162 |
|
|
2019
Q3 | $2K | Hold |
583
| – | – | ﹤0.01% | 1129 |
|
|
2019
Q2 | $4K | Hold |
583
| – | – | ﹤0.01% | 1117 |
|
|
2019
Q1 | $3K | Hold |
583
| – | – | ﹤0.01% | 1107 |
|
|
2018
Q4 | $4K | Hold |
583
| – | – | ﹤0.01% | 1073 |
|
|
2018
Q3 | $6K | Hold |
583
| – | – | ﹤0.01% | 1072 |
|
|
2018
Q2 | $7K | Hold |
583
| – | – | ﹤0.01% | 1072 |
|
|
2018
Q1 | $5K | Buy |
+583
| New | +$5.39K | ﹤0.01% | 1074 |
|
Other funds holding LXRX
AG
SL
SC
